Financhill
Sell
30

ARCT Quote, Financials, Valuation and Earnings

Last price:
$6.51
Seasonality move :
-11.37%
Day range:
$6.40 - $6.56
52-week range:
$5.85 - $24.17
Dividend yield:
0%
P/E ratio:
8.50x
P/S ratio:
2.07x
P/B ratio:
0.82x
Volume:
477.2K
Avg. volume:
841K
1-year change:
-60.68%
Market cap:
$184.8M
Revenue:
$138.4M
EPS (TTM):
-$2.46

Earnings Data

Next earnings date for ARCT
Mar 05
2026
Most recent earnings per share
-$0.49
Beat by $0.30
(Nov 10/2025)
Consensus Estimate
-$0.80
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARCT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/05/2026 Q4 $14.2M -- -- -$0.72 --
11/10/2025 Q3 $16M $14.2M -$0.49 -$0.80 $0.30
08/11/2025 Q2 $18.8M $24.5M -$0.34 -$0.85 $0.51
05/08/2025 Q1 $23.3M $25.5M -$0.52 -$1.10 $0.58
03/06/2025 Q4 $44.6M $21M -$1.11 -$0.49 -$0.62
11/07/2024 Q3 $36.6M $38.8M -$0.26 -$1.02 $0.76
08/05/2024 Q2 $22.2M $46M -$0.64 -$1.57 $0.93
05/08/2024 Q1 $17.7M $32.6M -$1.00 -$1.14 $0.14
03/07/2024 Q4 $37.9M $25.1M -$0.32 -$1.05 $0.73
11/14/2023 Q3 -- -- -$0.61 -$1.63 $1.02
08/07/2023 Q2 -- -- -$1.98 -$0.42 -$1.56
05/09/2023 Q1 -- -- $1.87 $0.65 $1.22
03/28/2023 Q4 -- -- $4.43 $1.23 $3.20
11/09/2022 Q3 -- -- -$1.33 -$1.81 $0.48
08/09/2022 Q2 -- -- -$0.82 -$1.88 $1.06
05/09/2022 Q1 -- -- -$1.94 -$1.40 -$0.54
02/28/2022 Q4 -- -- -$1.47 -$1.69 $0.22
11/08/2021 Q3 -- -- -$2.05 -$1.52 -$0.53
08/10/2021 Q2 -- -- -$2.07 -$2.25 $0.18
05/10/2021 Q1 -- -- -$2.15 -$1.23 -$0.92
03/01/2021 Q4 -- -- -$1.36 -$0.86 -$0.50
11/09/2020 Q3 -- -- -$0.92 -$0.49 -$0.43
08/10/2020 Q2 -- -- -$0.55 -- --
05/07/2020 Q1 -- -- -$0.67 -$0.72 $0.05
03/11/2020 Q4 -- -- -$0.76 -$0.63 -$0.13
11/07/2019 Q3 -- -- -$0.56 -$0.65 $0.09
08/15/2019 Q2 -- -- -- -$0.67 --
05/13/2019 Q1 -- -- -- -$0.60 --
03/18/2019 Q4 -- -- -- -$0.52 --
10/01/2018 Q3 -- -- -- -$0.35 --
06/30/2018 Q2 -- -- -- -$0.34 --
05/14/2018 Q1 -- -- -- -$0.33 --
12/31/2017 Q4 -- -- -- -- --
11/09/2017 Q3 -- -- -- -- --
08/11/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --
02/15/2017 Q4 -- -- -- -- --
11/15/2016 Q3 -- -- -- -- --
08/30/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --

Arcturus Therapeutics Holdings, Inc. Earnings Questions

  • How Much did Arcturus Therapeutics Holdings, Inc. Generate in Revenue Last Quarter?

    Arcturus Therapeutics Holdings, Inc. reported $14.2M worth of top line sales in its most recent quarter.

  • Did Arcturus Therapeutics Holdings, Inc. Beat Earnings Last Quarter?

    Arcturus Therapeutics Holdings, Inc. announced earnings per share of -$0.49 which represents a beat of analyst forecast a -$0.80 per share.

  • Is Arcturus Therapeutics Holdings, Inc. Profitable?

    Arcturus Therapeutics Holdings, Inc. reported $13.4M that represents $0.49 per share over the last quarter.

  • What is the Analyst Consensus for Arcturus Therapeutics Holdings, Inc. EPS Next Year?

    Arcturus Therapeutics Holdings, Inc.'s earnings are forecast to decrease from -$3.00 per share to -$2.38 per share next year representing a decrease of -30.52%.

  • When is Arcturus Therapeutics Holdings, Inc.'s Earnings Date?

    Arcturus Therapeutics Holdings, Inc.'s next earnings date is March 5, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock